{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:49:13Z","timestamp":1740138553002,"version":"3.37.3"},"reference-count":72,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100007872","name":"Bowel and Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007872","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>While surgery plays a pivotal role in the management of ileal Crohn\u2019s disease, the risk of endoscopic recurrence following an ileocaecal resection can be greater than 65% within 12 months of surgery. More than 90% of patients with Crohn\u2019s disease have a concomitant diagnosis of bile acid diarrhea following an ileal resection. This pilot study aimed to assess whether the use of bile acid sequestrants in patients with Crohn\u2019s disease who have undergone a primary terminal ileal resection with concomitant bile acid diarrhea can alter the microbiome and prevent disease recurrence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with Crohn\u2019s disease who underwent a primary terminal ileal resection and had symptoms of diarrhea within 1-3 months of surgery underwent 75SeHCAT testing for bile acid diarrhea. If positive (75SeHCAT\u2005\u2264\u200515%), patients were treated with colesevelam and stool samples were collected at 4 weeks, 8 weeks, and 6-12 months posttreatment. If negative (75SeHCAT\u2005&amp;gt;\u200515%), treatment was not given and were reviewed in the clinic as per local guidelines. All patients underwent a 6-12 month postoperative colonoscopy where further stool samples and mucosal biopsies were taken. Disease activity was established using the endoscopic Rutgeert\u2019s score, with disease remission defined as Rutgeert\u2019s score &amp;lt;i2 and disease recurrence \u2265i2. 16S ribosomal RNA gene analysis was undertaken for the collected fecal and mucosal samples to assess \u03b1\/\u03b2-diversity and microbial composition.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 14 patients who completed the study, 10 of whom had a 75SeHCAT positive diagnosis of bile acid diarrhea and were started on treatment with colesevelam. Four patients did not require treatment as 3 were asymptomatic and 1 had a negative 75SeHCAT scan. Three of the fourteen patients had disease recurrence at their 6-12 month postoperative colonoscopy assessment, of which 1 patient was taking colesevelam and 2 patients were not taking colesevelam. A total of 44 fecal samples and 44 mucosal biopsies underwent 16S ribosomal RNA gene analysis to assess \u03b1\/\u03b2-diversity and microbial composition. In the colesevelam treated patients there was no significant difference in \u03b1\/\u03b2-diversity pre- and posttreatment. Pretreatment, the 3 most abundant bacterial classes in all patients were Bacteroidia, Clostridia, and Gammaproteobacteria. Following 6-12 months of treatment, out of the 9 patients on colesevelam, 5\/9 (55.6%) had a reduction in Bacteroidia, 9\/9 (100%) had an increase in Clostridia, and 7\/9 (77.8%) had a reduction in Gammaproteobacteria. Of the 2 patients not given colesevelam, one showed a reduction in Bacteroidia, increase in Clostridia and a reduction in Gammaproteobacteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This small pilot study demonstrated that patients who were given colesevelam, were more likely to be in disease remission at their 6-12 months colonoscopy review compared with those not treated. Furthermore, treatment with colesevelam may have a role in altering the microbiome to help maintain remission states in postoperative Crohn\u2019s disease. Larger mechanistic studies are now needed to confirm these findings and demonstrate statistical significance as well as investigate whether this benefit may be present even in those patients with 75SeHCAT negative disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izae230","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T14:51:42Z","timestamp":1729263102000},"page":"539-551","source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Colesevelam on the Microbiome in Postoperative Crohn\u2019s Disease"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1026-3173","authenticated-orcid":false,"given":"Aditi","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The Royal Wolverhampton NHS Trust , Wolverhampton ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Nabil","family":"Quraishi","sequence":"additional","affiliation":[{"name":"University of Birmingham Microbiome Treatment Centre , Birmingham ,","place":["UK"]},{"name":"Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust , Birmingham ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafid O","family":"Al-Hassi","sequence":"additional","affiliation":[{"name":"Research Institute in Healthcare Science, University of Wolverhampton , Wolverhampton ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Elasrag","sequence":"additional","affiliation":[{"name":"Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham ,","place":["UK"]},{"name":"Aston Medical School, College of Health and Life Sciences, Aston University , Birmingham ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan P","family":"Segal","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Royal Melbourne Hospital , Melbourne, VIC ,","place":["Australia"]},{"name":"Department of Medicine, University of Melbourne , Parkville, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manushri","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Royal Wolverhampton NHS Trust , Wolverhampton ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Steed","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Royal Wolverhampton NHS Trust , Wolverhampton ,","place":["UK"]},{"name":"School of Medicine and Clinical Practice, Faculty of Sciences and Engineering, University of Wolverhampton , Wolverhampton ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Butterworth","sequence":"additional","affiliation":[{"name":"Shrewsbury and Telford Hospital NHS Trust , Shrewsbury ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Farmer","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, St Louis University Hospital , St Louis, MO ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Mclaughlin","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre , Manchester ,","place":["UK"]},{"name":"Department of Gastroenterology, Salford Royal Foundation Trust , Stott Lane ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0784-2967","authenticated-orcid":false,"given":"Andrew D","family":"Beggs","sequence":"additional","affiliation":[{"name":"University of Birmingham Microbiome Treatment Centre , Birmingham ,","place":["UK"]},{"name":"Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J","family":"Brookes","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Royal Wolverhampton NHS Trust , Wolverhampton ,","place":["UK"]},{"name":"School of Medicine and Clinical Practice, Faculty of Sciences and Engineering, University of Wolverhampton , Wolverhampton ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"issue":"7","key":"2025021012304743800_CIT0001","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.mayocp.2017.04.010","article-title":"Crohn Disease: epidemiology, diagnosis, and management","volume":"92","author":"Feuerstein","year":"2017","journal-title":"Mayo Clin Proc."},{"key":"2025021012304743800_CIT0002","doi-asserted-by":"publisher","first-page":"7270486","DOI":"10.1155\/2018\/7270486","article-title":"Lipid and bile acid dysmetabolism in Crohn\u2019s Disease","volume":"2018","author":"Uchiyama","year":"2018","journal-title":"J Immunol Res"},{"issue":"5","key":"2025021012304743800_CIT0003","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology."},{"issue":"9","key":"2025021012304743800_CIT0004","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting therapeutic targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol."},{"issue":"5","key":"2025021012304743800_CIT0005","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/j.gastro.2013.07.041","article-title":"Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies","volume":"145","author":"Frolkis","year":"2013","journal-title":"Gastroenterology."},{"issue":"11","key":"2025021012304743800_CIT0006","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/ajg.2014.297","article-title":"Cumulative incidence of second intestinal resection in Crohn\u2019s disease: a systematic review and meta-analysis of population-based studies","volume":"109","author":"Frolkis","year":"2014","journal-title":"Am J Gastroenterol."},{"issue":"2","key":"2025021012304743800_CIT0007","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/ajg.2016.524","article-title":"Improvements in the long-term outcome of Crohn\u2019s disease over the past two decades and the relation to changes in medical management: results from the population-based IBDSL cohort","volume":"112","author":"Jeuring","year":"2017","journal-title":"Am J Gastroenterol."},{"issue":"1","key":"2025021012304743800_CIT0008","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.gastro.2011.03.050","article-title":"Outcomes of patients with Crohn\u2019s disease improved from 1988 to 2008 and were associated with increased specialist care","volume":"141","author":"Nguyen","year":"2011","journal-title":"Gastroenterology."},{"issue":"3","key":"2025021012304743800_CIT0009","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/gastro\/gow046","article-title":"Perioperative use of immunosuppressive medications in patients with Crohn\u2019s disease in the new \u201cbiological era.\u201d","volume":"5","author":"Lightner","year":"2017","journal-title":"Gastroenterology Report"},{"issue":"11","key":"2025021012304743800_CIT0010","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S2468-1253(17)30248-0","article-title":"Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn\u2019s disease: a Randomised Controlled, open-label, multicentre trial","volume":"2","author":"Ponsioen","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025021012304743800_CIT0011","doi-asserted-by":"publisher","first-page":"i36","DOI":"10.1136\/gut.2005.081950c","article-title":"European evidence based consensus on the diagnosis and management of Crohn\u2019s disease: special situations","volume":"55","author":"Caprilli","year":"2006","journal-title":"Gut."},{"issue":"3","key":"2025021012304743800_CIT0012","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1136\/gut.33.3.331","article-title":"Natural course of Crohn\u2019s disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms","volume":"33","author":"Olaison","year":"1992","journal-title":"Gut."},{"issue":"2","key":"2025021012304743800_CIT0013","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000323922","article-title":"From aphthous ulcer to full-blown Crohn\u2019s disease","volume":"29","author":"Rutgeerts","year":"2011","journal-title":"Dig Dis."},{"issue":"6","key":"2025021012304743800_CIT0014","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.cgh.2007.08.020","article-title":"Prevention of postoperative recurrence in Crohn\u2019s disease","volume":"6","author":"Terdiman","year":"2008","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"6","key":"2025021012304743800_CIT0015","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/gut.25.6.665","article-title":"Natural history of recurrent Crohn\u2019s disease at the ileocolonic anastomosis after curative surgery","volume":"25","author":"Rutgeerts","year":"1984","journal-title":"Gut."},{"issue":"10080","key":"2025021012304743800_CIT0016","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet."},{"issue":"3","key":"2025021012304743800_CIT0017","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.gtc.2017.05.004","article-title":"The Microbiome in Crohn\u2019s Disease: role in pathogenesis and role of microbiome replacement therapies","volume":"46","author":"Khanna","year":"2017","journal-title":"Gastroenterol Clin North Am."},{"issue":"1","key":"2025021012304743800_CIT0018","doi-asserted-by":"publisher","first-page":"2083419","DOI":"10.1080\/19490976.2022.2083419","article-title":"Gut microbiota in mucosa and feces of newly diagnosed, treatment-na\u00efve adult inflammatory bowel disease and irritable bowel syndrome patients","volume":"14","author":"\u010cip\u010di\u0107 Paljetak","year":"2022","journal-title":"Gut Microbes"},{"issue":"5","key":"2025021012304743800_CIT0019","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3390\/cells11050901","article-title":"Bile acids: key players in inflammatory bowel diseases","volume":"11","author":"Kriaa","year":"2022","journal-title":"Cells"},{"key":"2025021012304743800_CIT0020","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/bmb\/ldp032","article-title":"Recent advances in the understanding of bile acid malabsorption","volume":"92","author":"Pattni","year":"2009","journal-title":"Br Med Bull."},{"issue":"11","key":"2025021012304743800_CIT0021","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.crohns.2014.05.009","article-title":"Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn\u2019s disease: a randomized, double-blind, placebo-controlled study","volume":"8","author":"Beigel","year":"2014","journal-title":"J Crohns Colitis."},{"issue":"Supplement_1","key":"2025021012304743800_CIT0022","doi-asserted-by":"publisher","first-page":"S470","DOI":"10.1093\/ecco-jcc\/jjy222.824","article-title":"P700 The efficacy of colesevelam to treat bile acid malabsorption in Crohn\u2019s disease: data from TOPPIC trial","volume":"13","author":"Devarakonda","year":"2019","journal-title":"J Crohns Colitis."},{"issue":"1","key":"2025021012304743800_CIT0023","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Halilbasic","year":"2013","journal-title":"J Hepatol."},{"issue":"5","key":"2025021012304743800_CIT0024","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/flgastro-2019-101301","article-title":"Diagnosis and management of bile acid diarrhoea: a survey of UK expert opinion and practice","volume":"11","author":"Walters","year":"2020","journal-title":"Frontline Gastroenterol"},{"issue":"11","key":"2025021012304743800_CIT0025","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/j.clinthera.2009.11.027","article-title":"Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire","volume":"31","author":"Wedlake","year":"2009","journal-title":"Clin Ther."},{"volume-title":"DG44: SeHCAT (tauroselcholic[75 selenium] acid) for Diagnosing Bile Acid Diarrhoea","author":"NICE Guidelines","key":"2025021012304743800_CIT0026"},{"issue":"7","key":"2025021012304743800_CIT0027","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1007\/s10620-005-2765-8","article-title":"Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type IIa hypercholesterolemia","volume":"50","author":"Donovan","year":"2005","journal-title":"Dig Dis Sci."},{"issue":"3","key":"2025021012304743800_CIT0028","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1345\/aph.1A143","article-title":"Absorption of colesevelam hydrochloride in healthy volunteers","volume":"36","author":"Heller","year":"2002","journal-title":"Ann Pharmacother."},{"key":"2025021012304743800_CIT0029","doi-asserted-by":"publisher","first-page":"1134105","DOI":"10.3389\/fmicb.2023.1134105","article-title":"The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam","volume":"14","author":"Kumar","year":"2023","journal-title":"Front Microbiol."},{"issue":"8","key":"2025021012304743800_CIT0030","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1136\/gutjnl-2017-315909","article-title":"Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition","volume":"67","author":"Arasaradnam","year":"2018","journal-title":"Gut."},{"key":"2025021012304743800_CIT0031","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut."},{"issue":"7681","key":"2025021012304743800_CIT0032","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature24621","article-title":"A communal catalogue reveals Earth\u2019s multiscale microbial diversity","volume":"551","author":"Thompson","year":"2017","journal-title":"Nature."},{"issue":"8","key":"2025021012304743800_CIT0033","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat Biotechnol."},{"issue":"12","key":"2025021012304743800_CIT0034","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.tree.2017.09.012","article-title":"Information theory broadens the spectrum of molecular ecology and evolution","volume":"32","author":"Sherwin","year":"2017","journal-title":"Trends Ecol Evol."},{"issue":"1558","key":"2025021012304743800_CIT0035","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1098\/rstb.2010.0272","article-title":"Phylogenetic diversity measures based on hill numbers","volume":"365","author":"Chao","year":"2010","journal-title":"Philos Trans R Soc London Ser B."},{"issue":"6","key":"2025021012304743800_CIT0036","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"issue":"16","key":"2025021012304743800_CIT0037","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for Genomewide studies","volume":"100","author":"Storey","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"2025021012304743800_CIT0038","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.crohns.2009.09.009","article-title":"The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: special situations","volume":"4","author":"Van Assche","year":"2010","journal-title":"J Crohns Colitis."},{"issue":"6","key":"2025021012304743800_CIT0039","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/0016-5085(85)90007-1","article-title":"Recurrence after surgery in Crohn\u2019s disease. Relationship to location of disease (clinical pattern) and surgical indication","volume":"88","author":"Whelan","year":"1985","journal-title":"Gastroenterology."},{"issue":"5","key":"2025021012304743800_CIT0040","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1053\/j.gastro.2008.07.066","article-title":"Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn\u2019s disease","volume":"135","author":"Renna","year":"2008","journal-title":"Gastroenterology."},{"issue":"1","key":"2025021012304743800_CIT0041","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00000658-200001000-00006","article-title":"Risk factors for surgery and postoperative recurrence in Crohn\u2019s disease","volume":"231","author":"Bernell","year":"2000","journal-title":"Ann Surg."},{"key":"2025021012304743800_CIT0042","doi-asserted-by":"publisher","first-page":"S179","DOI":"10.1002\/ibd.20655","article-title":"What is the role of endoscopy in the postoperative management of Crohn\u2019s disease","volume":"14","author":"Rutgeerts","year":"2008","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"2025021012304743800_CIT0043","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.amjsurg.2003.11.007","article-title":"Crohn\u2019s disease patients who quit smoking have a reduced risk of reoperation for recurrence","volume":"187","author":"Ryan","year":"2004","journal-title":"Am J Surg."},{"issue":"2","key":"2025021012304743800_CIT0044","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s11605-008-0726-1","article-title":"Frequency, pattern, and risk factors of postoperative recurrence of Crohn\u2019s disease after resection different from ileo-colonic","volume":"13","author":"Onali","year":"2009","journal-title":"J Gastrointest Surg."},{"issue":"7","key":"2025021012304743800_CIT0045","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/ibd.20872","article-title":"Recurrence patterns after first resection for stricturing or penetrating Crohn\u2019s disease","volume":"15","author":"Sachar","year":"2009","journal-title":"Inflamm Bowel Dis."},{"issue":"37","key":"2025021012304743800_CIT0046","first-page":"152","article-title":"The impact of clinical types of disease manifestation on the risk of early postoperative recurrence in Crohn\u2019s disease","volume":"48","author":"Hofer","year":"2001","journal-title":"Hepatogastroenterology."},{"issue":"4","key":"2025021012304743800_CIT0047","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/ibd\/izx108","article-title":"The management of intestinal penetrating Crohn\u2019s Disease","volume":"24","author":"Hirten","year":"2018","journal-title":"Inflamm Bowel Dis."},{"issue":"27","key":"2025021012304743800_CIT0048","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.3748\/wjg.v17.i27.3213","article-title":"Risk of postoperative recurrence and postoperative management of Crohn\u2019s disease","volume":"17","author":"Spinelli","year":"2011","journal-title":"World J Gastroenterol."},{"issue":"1","key":"2025021012304743800_CIT0049","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12915-019-0699-4","article-title":"The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health","volume":"17","author":"Waters","year":"2019","journal-title":"BMC Biol."},{"issue":"6","key":"2025021012304743800_CIT0050","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/gutjnl-2020-321173","article-title":"Bacteria-derived long chain fatty acid exhibits anti-Inflammatory properties in Colitis","volume":"70","author":"Pujo","year":"2021","journal-title":"Gut."},{"issue":"1","key":"2025021012304743800_CIT0051","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1849998","article-title":"From correlation to causality: the case of Subdoligranulum","volume":"12","author":"Van Hul","year":"2020","journal-title":"Gut Microbes"},{"issue":"2","key":"2025021012304743800_CIT0052","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/jgh.12694","article-title":"Association between specific mucosa-associated microbiota in Crohn\u2019s disease at the time of resection and subsequent disease recurrence: a pilot study","volume":"30","author":"De Cruz","year":"2015","journal-title":"J Gastroenterol Hepatol."},{"issue":"6","key":"2025021012304743800_CIT0053","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1097\/MIB.0000000000000036","article-title":"Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn\u2019s disease","volume":"20","author":"Rajca","year":"2014","journal-title":"Inflamm Bowel Dis."},{"issue":"6","key":"2025021012304743800_CIT0054","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3390\/microorganisms9061302","article-title":"Gut Microbiota and host metabolism: from proof of concept to therapeutic intervention","volume":"9","author":"Cani","year":"2021","journal-title":"Microorganisms"},{"issue":"4","key":"2025021012304743800_CIT0055","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1053\/j.gastro.2017.11.003","article-title":"Enteric delivery of regenerating family member 3 alpha alters the Intestinal Microbiota and Controls Inflammation in Mice with Colitis","volume":"154","author":"Darnaud","year":"2018","journal-title":"Gastroenterology."},{"issue":"1","key":"2025021012304743800_CIT0056","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1826748","article-title":"Butyrate mediates Anti-Inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3","volume":"12","author":"Lenoir","year":"2020","journal-title":"Gut Microbes"},{"key":"2025021012304743800_CIT0057","doi-asserted-by":"publisher","first-page":"1191126","DOI":"10.3389\/fcimb.2023.1191126","article-title":"Alterations of gut microbiome following gastrointestinal surgical procedures and their potential complications","volume":"13","author":"Tsigalou","year":"2023","journal-title":"Front Cell Infect Microbiol."},{"issue":"2","key":"2025021012304743800_CIT0058","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/ecco-jcc\/jjw136","article-title":"Microbial factors associated with postoperative Crohn\u2019s Disease recurrence","volume":"11","author":"Wright","year":"2017","journal-title":"J Crohns Colitis."},{"issue":"6","key":"2025021012304743800_CIT0059","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/gutjnl-2015-309184","article-title":"Structural robustness of the gut mucosal microbiota is associated with Crohn\u2019s disease remission after surgery","volume":"65","author":"Mondot","year":"2016","journal-title":"Gut."},{"issue":"5","key":"2025021012304743800_CIT0060","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s13238-018-0543-6","article-title":"The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get","volume":"9","author":"Yang","year":"2018","journal-title":"Protein Cell."},{"issue":"2","key":"2025021012304743800_CIT0061","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2036.2007.03562.x","article-title":"Review article: the role of butyrate on colonic function","volume":"27","author":"Hamer","year":"2008","journal-title":"Aliment Pharmacol Ther."},{"issue":"2","key":"2025021012304743800_CIT0062","doi-asserted-by":"publisher","first-page":"e0213108","DOI":"10.1371\/journal.pone.0213108","article-title":"Influence of Crohn\u2019s disease related polymorphisms in innate immune function on ileal microbiome","volume":"14","author":"Li","year":"2019","journal-title":"PLoS One."},{"key":"2025021012304743800_CIT0063","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.01486","article-title":"Short chain fatty acids (SCFAs)-Mediated Gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front Immunol."},{"issue":"10","key":"2025021012304743800_CIT0064","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1128\/JCM.01396-12","article-title":"Microbial dysbiosis in pediatric patients with Crohn\u2019s disease","volume":"50","author":"Kaakoush","year":"2012","journal-title":"J Clin Microbiol."},{"issue":"1","key":"2025021012304743800_CIT0065","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/ibd.21339","article-title":"Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases","volume":"17","author":"Frank","year":"2011","journal-title":"Inflamm Bowel Dis."},{"issue":"9","key":"2025021012304743800_CIT0066","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","article-title":"Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment","volume":"13","author":"Morgan","year":"2012","journal-title":"Genome Biol."},{"issue":"1","key":"2025021012304743800_CIT0067","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s40168-022-01331-x","article-title":"Location-specific signatures of Crohn\u2019s disease at a multi-omics scale","volume":"10","author":"Gonzalez","year":"2022","journal-title":"Microbiome"},{"issue":"1","key":"2025021012304743800_CIT0068","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12876-020-01281-4","article-title":"Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn\u2019s disease","volume":"20","author":"Strombeck","year":"2020","journal-title":"BMC Gastroenterol."},{"issue":"6","key":"2025021012304743800_CIT0069","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1080\/19490976.2020.1778262","article-title":"Luminal microbiota related to Crohn\u2019s disease recurrence after surgery","volume":"11","author":"Hamilton","year":"2020","journal-title":"Gut Microbes"},{"issue":"3","key":"2025021012304743800_CIT0070","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/gutjnl-2019-318719","article-title":"Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn\u2019s disease","volume":"69","author":"Sokol","year":"2020","journal-title":"Gut."},{"key":"2025021012304743800_CIT0071","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nmicrobiol.2017.4","article-title":"Dynamics of the human gut microbiome in inflammatory bowel disease","volume":"2","author":"Halfvarson","year":"2017","journal-title":"Nat Microbiol."},{"issue":"6","key":"2025021012304743800_CIT0072","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/2\/539\/59874732\/izae230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/2\/539\/59874732\/izae230.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T12:38:14Z","timestamp":1739191094000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/2\/539\/7826566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":72,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,10,18]]},"published-print":{"date-parts":[[2025,2,10]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izae230","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"type":"print","value":"1078-0998"},{"type":"electronic","value":"1536-4844"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,10,18]]}}}